Crunching the numbers for AMRN... Refresh in a moment for the full analysis.
AMARIN CORP PLC\UK (AMRN)
Healthcare
mixed
$14.45
Updated: 2026-04-07
Financial Strength
50
Mixed
Capital Allocation
50
Mixed
Key Findings
+
Free cash flow positive — business generates real spendable cash
−
Weak interest coverage — earnings barely cover debt service
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.